Skip to content

Independence Blue Cross

Does Independence Blue Cross cover Wegovy?

Yes. Independence Blue Cross covers Wegovy for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.

Policy document

  • Independence Blue Cross Employer / Commercial Insurance prior authorization policy

    Independence Blue Cross · PA policy · Employer

    View PDF Download
  • Employer: Covered with requirements. See the qualification pathways below.

Earliest policy review April 1, 2026. How we verify · Check your exact plan

Full requirements: Wegovy for Weight Loss (1 plan type)

Applies to Employer plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Adult patients (18+) with obesity

All of:

  • Member is 18 years of age or older
  • Documentation (e.g., chart note) confirming BMI ≥ 30 kg/m2
  • Drug used as adjunct to lifestyle modification
  • No concurrent use of any other GLP-1 receptor agonist (e.g., Ozempic, Rybelsus, Trulicity, Victoza)

Adult patients (18+) with overweight and comorbidity

All of:

  • Member is 18 years of age or older
  • Documentation (e.g., chart note) confirming BMI ≥ 27 kg/m2
  • One or more comorbidities (e.g., hypertension, coronary artery disease, type 2 diabetes mellitus, dyslipidemia, or obstructive sleep apnea)
  • Drug used as adjunct to lifestyle modification
  • No concurrent use of any other GLP-1 receptor agonist (e.g., Ozempic, Rybelsus, Trulicity, Victoza)

Pediatric patients (12-17 years) with obesity

All of:

  • Member is 12 to 17 years of age
  • Documentation (e.g., chart note) confirming initial BMI at the 95th percentile or greater for age and sex (obesity)
  • Drug used as adjunct to lifestyle modification
  • No concurrent use of any other GLP-1 receptor agonist (e.g., Ozempic, Rybelsus, Trulicity, Victoza)

Documentation to bring

  • Chart note confirming BMI ≥ 30 kg/m2 OR BMI ≥ 27 kg/m2 with at least one qualifying comorbidity (adults 18+)
  • Chart note confirming BMI at 95th percentile or greater for age and sex (pediatric patients 12-17)
  • Documentation confirming no concurrent use of another GLP-1 receptor agonist
  • For reauthorization: chart note confirming weight loss ≥ 5% from baseline body weight

Approval and renewal

  • Initial approval: 6 months
  • Renewal: every 6 months
  • Renewal: Weight loss of ≥ 5% from baseline body weight required for reauthorization. Concurrent GLP-1 restriction and lifestyle modification adjunct use are re-verified. Initial BMI/comorbidity criteria are NOT re-checked at reauthorization.

Not covered when

  • Personal or family history of medullary thyroid carcinoma (MTC) - contraindication per black box warning
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) - contraindication per black box warning
  • Concurrent use of any other GLP-1 receptor agonist

Policy note: Policy is titled 'Weight Loss Agents' (Rx.01.94). Wegovy is listed only under chronic weight management for weight loss indication in this document. No CV risk reduction, MASH, or other indications are covered in this policy. Pediatric approval (ages 12-17) requires BMI at 95th percentile or greater for age and sex per Cole Criteria. No quantity limits specified in this document. Initial authorization is 7 months; reauthorization is 6 months.

source: Independence Blue Cross Employer / Commercial Insurance prior authorization policy · View policy document (PDF)

Open on its own page →

Questions people ask
Does Independence Blue Cross cover Wegovy?
Yes. Independence Blue Cross covers Wegovy for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.
How long does a Wegovy approval last with Independence Blue Cross?
Weight Loss — Applies to Employer plans. Initial approval: 6 months. Renewal: every 6 months.
What does Independence Blue Cross require to renew Wegovy?
Weight Loss — Applies to Employer plans. Weight loss of ≥ 5% from baseline body weight required for reauthorization. Concurrent GLP-1 restriction and lifestyle modification adjunct use are re-verified. Initial BMI/comorbidity criteria are NOT re-checked at reauthorization.
How current is this information?
The oldest review date among the policies on this page is April 1, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Also under Independence Blue Cross: Ozempic

Wegovy under other plans: Capital BlueCross, Highmark, Horizon BCBS, Pennsylvania Medicaid, BCBS Alabama, BCBS Arizona, BCBS Arkansas, BCBS Louisiana

All insurance plans · All medications

Summary of Independence Blue Cross's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.